What is CKD Staging?
Chronic Kidney Disease (CKD) staging is a standardized way for healthcare providers to classify the severity of kidney disease. It helps in determining the prognosis, guiding treatment decisions, and deciding when a patient should be referred to a nephrologist.
The internationally recognized system for staging CKD was developed by KDIGO (Kidney Disease: Improving Global Outcomes). Unlike older systems that relied solely on the estimated Glomerular Filtration Rate (eGFR), the current KDIGO guidelines incorporate two crucial dimensions of kidney health: eGFR and Albuminuria (protein in the urine).
Understanding the KDIGO Heat Map
The KDIGO staging system functions like a "heat map," cross-referencing your eGFR category with your albuminuria category to determine an overall risk level. The risk levels assess the probability of disease progression, kidney failure, and cardiovascular events.
1. GFR Categories (The 'G' Stages)
- G1 (Normal or High): eGFR ≥ 90
- G2 (Mildly decreased): eGFR 60 - 89
- G3a (Mild to moderately decreased): eGFR 45 - 59
- G3b (Moderate to severely decreased): eGFR 30 - 44
- G4 (Severely decreased): eGFR 15 - 29
- G5 (Kidney failure): eGFR < 15
2. Albuminuria Categories (The 'A' Stages)
- A1 (Normal to mildly increased): ACR < 30 mg/g
- A2 (Moderately increased): ACR 30 - 300 mg/g (formerly known as microalbuminuria)
- A3 (Severely increased): ACR > 300 mg/g (formerly known as macroalbuminuria)
Prognosis and Risk Levels
By combining these categories (e.g., G3a, A2), healthcare providers can categorize patients into four risk groups, indicated by colors on the KDIGO heat map:
- Green (Low Risk): Normal function. No CKD unless there are other markers of kidney damage.
- Yellow (Moderately Increased Risk): Requires monitoring, blood pressure control, and lifestyle modifications to prevent progression.
- Orange (High Risk): Requires closer monitoring and specific interventions to slow progression and manage cardiovascular risk.
- Red (Very High Risk): Strong recommendation for referral to a nephrologist. High likelihood of progressing to end-stage kidney disease requiring dialysis or transplant.
Treatment Approaches by Stage
Treatment for CKD focuses on slowing progression and managing complications. In early stages (G1-G2), the focus is primarily on treating underlying conditions like diabetes and hypertension, as well as lifestyle changes like diet and exercise. In middle stages (G3), doctors may introduce medications specifically designed to protect the kidneys, such as ACE inhibitors, ARBs, or SGLT2 inhibitors, and manage complications like anemia or bone disease. In advanced stages (G4-G5), preparations for renal replacement therapy (dialysis or transplant) begin.
When to Refer to a Nephrologist
Timely referral to a kidney specialist (nephrologist) is crucial. Guidelines generally recommend a referral when a patient reaches stage G4 (eGFR < 30), exhibits rapidly declining kidney function, has severely increased albuminuria (A3), or faces challenges in managing complications like resistant hypertension or severe electrolyte imbalances.